Peter J. Mazzone

18.1k total citations · 7 hit papers
155 papers, 7.7k citations indexed

About

Peter J. Mazzone is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Peter J. Mazzone has authored 155 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Pulmonary and Respiratory Medicine, 33 papers in Oncology and 29 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Peter J. Mazzone's work include Lung Cancer Diagnosis and Treatment (82 papers), Lung Cancer Treatments and Mutations (48 papers) and Radiomics and Machine Learning in Medical Imaging (19 papers). Peter J. Mazzone is often cited by papers focused on Lung Cancer Diagnosis and Treatment (82 papers), Lung Cancer Treatments and Mutations (48 papers) and Radiomics and Machine Learning in Medical Imaging (19 papers). Peter J. Mazzone collaborates with scholars based in United States, United Kingdom and Canada. Peter J. Mazzone's co-authors include David P. Naidich, Renda Soylemez Wiener, Michael K. Gould, Frank C. Detterbeck, Jessica Donington, David E. Midthun, Tarek Mekhail, William R. Lynch, Louis Lam and Gerard A. Silvestri and has published in prestigious journals such as The Lancet, JAMA and Journal of Clinical Oncology.

In The Last Decade

Peter J. Mazzone

152 papers receiving 7.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evaluation of Individuals With Pulmonary Nodules: When Is It Lung Cancer?

2013 958 citations Michael K. Gould, Jessica Donington et al. CHEST Journal profile →
Detection of Lung Cancer by Sensor Array Analyses of Exhaled Breath

2005 483 citations Roberto F. Machado, Daniel Laskowski et al. American Journal of Respiratory and Critical Care Medicine profile →
Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges

2018 357 citations Javier J. Zulueta, Avrum Spira et al. Journal of Thoracic Oncology profile →
Incidence of Pneumonitis With Use of Programmed Death 1 and Programmed Death-Ligand 1 Inhibitors in Non-Small Cell Lung Cancer

2017 349 citations Peter J. Mazzone et al. CHEST Journal profile →
Screening for Lung Cancer

2013 325 citations Frank C. Detterbeck, Peter J. Mazzone et al. CHEST Journal profile →
Evaluating the Patient With a Pulmonary Nodule

2022 230 citations Peter J. Mazzone et al. profile →
Screening for Lung Cancer

2021 127 citations Peter J. Mazzone, Gerard A. Silvestri et al. CHEST Journal profile →

Peers

Countries citing papers authored by Peter J. Mazzone

Since Specialization

Citations

This map shows the geographic impact of Peter J. Mazzone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J. Mazzone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J. Mazzone more than expected).

Fields of papers citing papers by Peter J. Mazzone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter J. Mazzone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J. Mazzone. The network helps show where Peter J. Mazzone may publish in the future.

Co-authorship network of co-authors of Peter J. Mazzone

This figure shows the co-authorship network connecting the top 25 collaborators of Peter J. Mazzone. A scholar is included among the top collaborators of Peter J. Mazzone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter J. Mazzone. Peter J. Mazzone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The American Cancer Society National Lung Cancer Roundtable strategic plan: Current challenges and future directions for shared decision making for lung cancer screening 2024 ·Cancer ·Robert J. Volk, Ronald E. Myers, Douglas A. Arenberg, Tanner Caverly, Richard M. Hoffman, Hormuzd A. Katki, Peter J. Mazzone, Benjamin Moulton, Daniel S. Reuland, Nichole T. Tanner, Robert A. Smith, Renda Soylemez Wiener	3
2	A Nasal Swab Classifier to Evaluate the Probability of Lung Cancer in Patients With Pulmonary Nodules 2023 ·CHEST Journal ·Carla Lamb, Kimberly Rieger‐Christ, Chakravarthy Reddy, Jing Huang, (unknown), Marla Johnson, P. Sean Walsh, William A. Bulman, Lori Lofaro, Momen M. Wahidi, David Feller‐Kopman, Avrum Spira, Giulia C. Kennedy, Peter J. Mazzone	3
3	Abstract 5766: Prospective evaluation of cell-free DNA fragmentomes for lung cancer detection 2023 ·Cancer Research ·Peter J. Mazzone, Kwok‐Kin Wong, Jun-Chieh J. Tsay, Harvey I. Pass, Anil Vachani, (unknown), Jacob Carey, (unknown), Tony Wu, (unknown), (unknown), Keith Lumbard, (unknown), Nicholas C. Dracopoli, Tara Maddala, Peter B. Bach, Robert B. Scharpf, Victor E. Velculescu	2
4	Outcomes From More Than 1 Million People Screened for Lung Cancer With Low-Dose CT Imaging 2023 ·CHEST Journal ·Gerard A. Silvestri, Lenka Goldman, Nichole T. Tanner, Judy Burleson, Michael K. Gould, Ella A. Kazerooni, Peter J. Mazzone, M. Patricia Rivera, V. Paul Doria‐Rose, Lauren Rosenthal, (unknown), Robert A. Smith, Stacey A. Fedewa	58
5	Clinical validation and utility of Percepta GSC for the evaluation of lung cancer 2022 ·PLoS ONE ·Peter J. Mazzone, (unknown), Momen M. Wahidi, Michael Bernstein, Hans J. Lee, (unknown), Lonny Yarmus, Duncan Whitney, Christopher S. Stevenson, Jianghan Qu, Marla Johnson, P. Sean Walsh, Jing Huang, Lori Lofaro, Sangeeta Bhorade, Giulia C. Kennedy, Avrum Spira, M. Patricia Rivera, (unknown), (unknown)	6
6	The Integral Role of the Electronic Health Record and Tracking Software in the Implementation of Lung Cancer Screening—A Call to Action to Developers 2019 ·CHEST Journal ·Joelle T. Fathi, Charles S. White, (unknown), Peter J. Mazzone, Robert A. Smith, Carey C. Thomson	23
7	Incorporating Coexisting Chronic Illness into Decisions about Patient Selection for Lung Cancer Screening. An Official American Thoracic Society Research Statement 2018 ·American Journal of Respiratory and Critical Care Medicine ·M. Patricia Rivera, Nichole T. Tanner, Gerard A. Silvestri, Frank C. Detterbeck, Martin C. Tammemägi, Robert P. Young, Christopher G. Slatore, Tanner Caverly, Cynthia M. Boyd, Dejana Braithwaite, Joelle T. Fathi, Michael K. Gould, Jonathan M. Iaccarino, Stephen P. Malkoski, Peter J. Mazzone, L.T. Tanoue, Nancy L. Schoenborn, Javier J. Zulueta, Renda Soylemez Wiener	66
8	Stakeholder Research Priorities for Smoking Cessation Interventions within Lung Cancer Screening Programs. An Official American Thoracic Society Research Statement 2017 ·American Journal of Respiratory and Critical Care Medicine ·Hasmeena Kathuria, Frank C. Detterbeck, Joelle T. Fathi, (unknown), Michael K. Gould, Denise Jolicoeur, Stephanie R. Land, Greta M. Massetti, Peter J. Mazzone, Gerard A. Silvestri, Christopher G. Slatore, Robert A. Smith, Anil Vachani, Steven B. Zeliadt, Renda Soylemez Wiener	25
9	Evaluating Molecular Biomarkers for the Early Detection of Lung Cancer: When Is a Biomarker Ready for Clinical Use? An Official American Thoracic Society Policy Statement 2017 ·American Journal of Respiratory and Critical Care Medicine ·Peter J. Mazzone, Catherine R. Sears, Douglas A. Arenberg, Mina Gaga, Michael K. Gould, Pierre P. Massion, (unknown), Charles A. Powell, Gerard A. Silvestri, Anil Vachani, Renda Soylemez Wiener	75
10	An Official American Thoracic Society/American College of Chest Physicians Policy Statement: Implementation of Low-Dose Computed Tomography Lung Cancer Screening Programs in Clinical Practice 2015 ·American Journal of Respiratory and Critical Care Medicine ·Renda Soylemez Wiener, Michael K. Gould, Douglas A. Arenberg, David H. Au, (unknown), Carla Lamb, Peter J. Mazzone, David E. Midthun, Maryann Napoli, David E. Ost, Charles A. Powell, M. Patricia Rivera, Christopher G. Slatore, Nichole T. Tanner, Anil Vachani, Juan P. Wisnivesky, (unknown)	164
11	Accuracy of volatile urine biomarkers for the detection and characterization of lung cancer 2015 ·BMC Cancer ·Peter J. Mazzone, Xiaofeng Wang, Sung Hee Lim, Humberto Choi, James R. Jett, Anil Vachani, Qi Zhang, Mary Beukemann, (unknown), (unknown), Paul Rhodes	25
12	The Analysis of Small Molecule Metabolite Profiles in the Blood as a Biomarker of Lung Cancer 2014 ·CHEST Journal ·Peter J. Mazzone, Xiaofeng Wang, (unknown), Qi Zhang, (unknown), Robert Mahoney, (unknown), Kirk L. Pappan	1
13	The Analysis of Volatile Organic Compound Profiles in the Breath as a Biomarker of Lung Cancer 2013 ·CHEST Journal ·Peter J. Mazzone, Xiaofeng Wang, Paul Rhodes, (unknown), Sung Hee Lim, (unknown), (unknown), Humberto Choi, James R. Jett	3
14	Evaluation of Individuals With Pulmonary Nodules: When Is It Lung Cancer? breakdown → 2013 ·CHEST Journal ·Michael K. Gould, Jessica Donington, William R. Lynch, Peter J. Mazzone, David E. Midthun, David P. Naidich, Renda Soylemez Wiener	958
15	The Effect of Metformin and Thiazolidinedione Use on Lung Cancer 2010 ·CHEST Journal ·Peter J. Mazzone, (unknown), Mary Beukemann, Meng Xu, (unknown), Madhu Sasidhar	4
16	A Comparison of Two Stereotactic Body Radiation Fractionation Schedules for Medically Inoperable Stage I Non-small Cell Lung Cancer: The Cleveland Clinic Experience 2009 ·Journal of Thoracic Oncology ·Kevin L. Stephans, T. Djemil, C.A. Reddy, S Gajdos, M.D. Kolar, David Mason, (unknown), Thomas W. Rice, Peter J. Mazzone, Michael Machuzak, Tarek Mekhail, Gregory M.M. Videtic	104
17	Bronchogenic Carcinoma after Lung Transplantation: Characteristics and Outcomes 2008 ·Journal of Thoracic Oncology ·Omar A. Minai, (unknown), Peter J. Mazzone, Marie Budev, Debasis Sahoo, Sudish C. Murthy, David P. Mason, Gösta Pettersson, Atul C. Mehta	35
18	Electromagnetic Navigation Diagnostic Bronchoscopy 2006 ·American Journal of Respiratory and Critical Care Medicine ·Thomas R. Gildea, Peter J. Mazzone, Demet Karnak, Moulay A. Meziane, Atul C. Mehta	304
19	Detection of Lung Cancer by Sensor Array Analyses of Exhaled Breath breakdown → 2005 ·American Journal of Respiratory and Critical Care Medicine ·Roberto F. Machado, Daniel Laskowski, (unknown), (unknown), Shuo Zheng, Peter J. Mazzone, Tarek Mekhail, Constance Jennings, James K. Stoller, (unknown), (unknown), Raed A. Dweik, Serpil C. Erzurum	483
20	Can the Electronic Nose Really Sniff out Lung Cancer? 2005 ·American Journal of Respiratory and Critical Care Medicine ·Serpil C. Erzurum, (unknown), Daniel Laskowski, Peter J. Mazzone, Tarek Mekhail, Constance Jennings, James K. Stoller, Roberto F. Machado, (unknown), (unknown), Raed A. Dweik	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact